Anesthesia and Respiratory Devices: Global Markets

Report Code: HLC167A

Publish Date: Feb 2014

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for anesthetic and respiratory devices reached $11.1 billion in 2012. This market is expected to grow to $12.4 billion in 2013 and $19.6 billion in 2018 with a compound annual growth rate (CAGR) of 9.5% for the five-year period, 2013 to 2018.

Report Includes

  • An overview of the global market for anesthesia and respiratory devices.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Discussion on key market participants, extensive product segments, technologies, trends and market dynamics, competitive intelligence, as well as geographic trends.
  • A look at the growth trajectory of the market in regards to increasing demand from the emerging economies, particularly China and India as they have a large number of patient populations and increasing medical tourism.
  • Comprehensive profiles of leading companies.

SCOPE OF THE REPORT

This research report incorporates an in-depth analysis of anesthetic and respiratory devices market including market estimations and trends through 2018. Major players, competitive intelligence, innovative technologies, market dynamics and geographic opportunities are discussed in detail in the report. The report discusses recent developments and product portfolios of the major players. Patent analysis in the report focuses on providing technological trends over last few years in regions such as the U.S., Europe and Japan. The report presents market analysis and estimates CAGR (compound annual growth rate) for anesthetic and respiratory devices.

ANALYST CREDENTIALS

Vijay Laxmi has more than 20 years of domain experience. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies.

Vijay Laxmi has authored market research studies in the healthcare domain. Subject matter of these include:

  • Various medical devices markets.
  • High-growth and niche markets in healthcare and the life sciences.
  • The home healthcare market.
  • Medical tourism.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Anesthesia and Respiratory Devices: Global Markets147Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY3Free
Chapter- 3: MARKET OVERVIEW26Free
Chapter- 4: PRODUCTS INCLUDED IN THE GLOBAL ANESTHESIA DEVICE MARKET 9Free
Chapter- 5: GLOBAL RESPIRATORY DEVICE MARKET BY PRODUCT29Free
Chapter- 6: GLOBAL ANESTHESIA DRUG MARKET BY SEGMENT5Free
Chapter- 7: DENTAL ANESTHESIA8Free
Chapter- 8: ROUTES OF ADMINISTRATION OF ANESTHESIA2Free
Chapter- 9: ANESTHESIA AND RESPIRATORY DEVICE MARKET BY REGION4Free
Chapter- 10: THE COMPETITIVE LANDSCAPE7Free
Chapter- 11: C. CRAMER & CO. GMBH44Free
Chapter- 12: PATENT ANALYSIS7Free

Related Reports

Global Markets for Asthma and COPD Drugs

Published - Aug 2012 | Publisher - Peggy Lehr | Code - PHM059B

The global market for asthma and chronic obstructive pulmonary disease (COPD) prescription drugs was valued at $34.9 billion in 2011. This figure is projected to reach $38 billion in 2012 and $47.1 billion in 2017, increasing at a five-year compound annual growth rate (CAGR) of 4.4%.

Pulmonary Drug Delivery Systems: Technologies and Global Markets

Published - Jan 2012 | Publisher - Usha Nagavarapu | Code - HLC094A

The global pulmonary drug delivery technologies market which was $19.6 billion in 2010 is expected to be around $22.5 billion by 2011. This global market is further projected to reach nearly $44 billion by 2016 at a compound annual growth rate (CAGR) of 14.3%.

Recent Reports

Surgical Equipment: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - HLC154C

The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Anesthesia and Respiratory Devices: Global Markets
Customize Report